Icosavax Inc (ICVX)

NASDAQ
39.46
-0.46(-1.15%)
After Hours
38.83
-0.63(-1.60%)
- Real-time Data
  • Volume:
    196,593
  • Bid/Ask:
    23.00/38.83
  • Day's Range:
    38.70 - 41.98
  • Type:Equity
  • Market:United States
  • ISIN:US45114M1099
  • CUSIP:00045114M109

ICVX Overview

Prev. Close
39.92
Day's Range
38.7-41.98
Revenue
3.62M
Open
41
52 wk Range
21.7-49.99
EPS
-
Volume
196,593
Market Cap
1.55B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
302,209
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
39,387,386
Next Earnings Date
Dec. 01, 2021
What is your sentiment on Icosavax Inc?
or
Market is currently closed. Voting is open during market hours.

Icosavax Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellNeutralStrong BuyStrong Buy
Technical IndicatorsStrong SellStrong SellSellStrong BuyBuy
SummaryStrong SellStrong SellNeutralStrong BuyStrong Buy

Icosavax Inc Company Profile

Icosavax Inc Company Profile

Sector
Services
Employees
0

Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-A12, an respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-121, a vaccine candidate with RSV target; IVX-241, a vaccine candidate with hMPV target; IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2^ target indication; and IVX-421, a variant RBD antigen with SARS-CoV-2^ target indication. The company was incorporated in 2017 and is headquartered in Seattle, Washington.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.